USP’s success in its mission to improve global public health through creation of standards and related programs depends in large part on the work of volunteers.
Coronavirus Disease 2019 (COVID-19)
While the global vaccination effort to curb the spread of COVID-19 continues to ramp up worldwide, access to COVID-19 vaccines, particularly in low- and middle-income countries, remains staggeringly low. In fact, low- and middle-income countries received less than one percent of available doses.
USP’s COVID-19 Vaccine Handling Toolkit is designed to help address the challenges nurses and other healthcare providers face every day in preparing, distributing and administering essential vaccines.
Access to quality raw materials and increased stakeholder collaboration are needed to help ensure availability of monoclonal antibody (mAb) treatments for COVID-19 in low- and middle-income countries (LMICs).
Another public health crisis looms in the wake of the COVID-19 pandemic.
Recent politicization of the COVID-19 vaccine development and approval process has led to a concerning loss of confidence in vital governmental institutions. Each day that goes by, the picture seems to grow darker. Politicians criticize scientists without cause.
The scale and speed of the global vaccine research and development effort in response to COVID-19 is unprecedented.
During the COVID-19 pandemic, we have become acutely aware of how precious time is and the potential repercussions of delays or inefficiencies.